Your browser doesn't support javascript.
loading
Post-radiation vascular lesions of the breast.
Ronen, Shira; Ivan, Doina; Torres-Cabala, Carlos A; Curry, Jonathan L; Tetzlaff, Michael T; Aung, Phyu P; Nagarajan, Priyadharsini; Suster, Saul; Prieto, Victor G.
  • Ronen S; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Ivan D; Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.
  • Torres-Cabala CA; Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.
  • Curry JL; Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.
  • Tetzlaff MT; Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.
  • Aung PP; Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.
  • Nagarajan P; Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.
  • Suster S; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Prieto VG; Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.
J Cutan Pathol ; 46(1): 52-58, 2019 Jan.
Article en En | MEDLINE | ID: mdl-30251277
ABSTRACT
Post-radiation vascular lesions are a rare complication most commonly seen in patients previously treated for breast cancer. The main two entities include angiosarcoma (AS), which are malignant tumors that have a poor prognosis, and atypical vascular lesions (AVL), which typically behave in a benign manner and only rarely progress to angiosarcoma. The overall incidence of these lesions is low, but it appears to be increasing. Histopathologic distinction of AVL and AS is essential due to different clinical outcomes and treatment. However, due to the occasional existence of overlapping clinical and histopathologic features, it may be sometimes difficult to render a definite diagnosis, particularly in small biopsies. Ancillary techniques are, in general, of little help for separating the borderland cases but, in some instances, immunohistochemical study (IHC) for Ki67 and IHC or fluorescence in situ hybridization analysis for MYC may help in the diagnosis of angiosarcoma. Herein we discuss the clinical characteristics, histopathologic features, management strategies, and outcome of these lesions, with special emphasis on their differential diagnosis.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Radiodermatitis / Neoplasias Cutáneas / Neoplasias de la Mama / Proteínas Proto-Oncogénicas c-myc / Antígeno Ki-67 / Hemangiosarcoma / Neoplasias Inducidas por Radiación Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Radiodermatitis / Neoplasias Cutáneas / Neoplasias de la Mama / Proteínas Proto-Oncogénicas c-myc / Antígeno Ki-67 / Hemangiosarcoma / Neoplasias Inducidas por Radiación Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans Idioma: En Año: 2019 Tipo del documento: Article